Finance

Lists
P0F:FRA
Egetis Therapeutics AB (publ)
€0.68
+1.50%
(+0.0100) 1D
Sep 4, 8:01:08 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for P0F...
Open
€0.68
High
€0.68
Low
€0.68
Mkt. cap
3.65B
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.69
52-wk low
€0.36
No. of employees
56
Open
€0.68
High
€0.68
Low
€0.68
Mkt. cap
3.65B
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.69
52-wk low
€0.36
No. of employees
56
News stories
From web sources and news partners
About Egetis Therapeutics AB (publ)
CEONicklas Westerholm
Employees56
Founded2006
Headquarters-
SectorBiotechnology
Websiteegetis.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
17.40M
17.80M
13.40M
17.40M
Cost of goods sold
13.90M
13.70M
13.60M
13.80M
Cost of revenue
13.90M
13.70M
13.60M
13.80M
Research and development expenses
33.00M
58.80M
28.90M
35.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48.30M
69.50M
61.70M
74.70M
Operating expense
80.10M
114.60M
92.70M
112.80M
Total operating expenses
94.00M
128.30M
106.30M
126.60M
Operating income
-76.60M
-110.50M
-92.90M
-109.20M
Other non operating income
-2.70M
1.50M
400.00K
-100.00K
EBT including unusual items
-82.40M
-119.30M
-94.50M
-108.90M
EBT excluding unusual items
-82.40M
-119.30M
-94.50M
-108.90M
Income tax expense
-
400.00K
-
-
Effective tax rate
-
-0.34%
-
-
Other operating expenses
-1.20M
-13.70M
2.10M
2.70M
Net income
-82.40M
-119.70M
-94.50M
-108.90M
Net profit margin
-473.56%
-672.47%
-705.22%
-625.86%
Earnings per share
-0.20
-0.30
-0.20
-0.20
Interest and investment income
1.00M
3.80M
4.30M
3.90M
Interest expense
-4.10M
-3.80M
-6.30M
-3.50M
Net interest expenses
-3.10M
-
-2.00M
400.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-66.50M
-110.15M
-82.80M
-99.10M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps